Last reviewed · How we verify
Treatment of acute, uncomplicated Plasmodium falciparum malaria
Approved treatments
- artesunate-amodiaquine (AS-AQ) · Yale University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Treatment of acute, uncomplicated Plasmodium falciparum malaria patent landscape — cliff calendar, originator estates, attackable patents
- Treatment of acute, uncomplicated Plasmodium falciparum malaria treatment landscape brief
- Treatment of acute, uncomplicated Plasmodium falciparum malaria treatment updates RSS
Frequently asked questions about Treatment of acute, uncomplicated Plasmodium falciparum malaria
What drugs treat Treatment of acute, uncomplicated Plasmodium falciparum malaria?
Tracked treatments include artesunate-amodiaquine (AS-AQ).
What is the treatment for Treatment of acute, uncomplicated Plasmodium falciparum malaria?
Standard treatment for Treatment of acute, uncomplicated Plasmodium falciparum malaria includes artesunate-amodiaquine (AS-AQ). See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Treatment of acute, uncomplicated Plasmodium falciparum malaria patent cliff · Treatment of acute, uncomplicated Plasmodium falciparum malaria CI report
- Treatment: artesunate-amodiaquine (AS-AQ) · Yale University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing